The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
MilliporeSigma’s latest innovation, the Milliflex Oasis System, offers enhanced benefits for pharmaceutical bioburden and water testing. It has 96 new features to increase result reliability and traceability while streamlining the bioburden testing workflow, the company reports.
The benefits of the new system include:
The system also offers an all-in-one filtration solution with sterilized, ready-to-use filtration units and pharmacopeia-compliant media for comfort and peace of mind for water and bioburden testing, according to the company. MilliporeSigma launched the Milliflex Oasis System on Jan. 29, 2020.
Source: MilliporeSigma
FDA Approves Pfizer Combination Regimen for Treating R/R Diffuse Large B-Cell Lymphoma
February 14th 2025The approval of an ADCETRIS combination regimen is based on positive data from a Phase III trial where the combination regimen demonstrated a clinically meaningful reduction in the risk of death.